{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:38:02Z","timestamp":1792881482632,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003123","name":"Fetal Medicine Foundation","doi-asserted-by":"publisher","award":["1037116"],"award-info":[{"award-number":["1037116"]}],"id":[{"id":"10.13039\/501100003123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajog.2019.02.034","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T20:38:41Z","timestamp":1550781521000},"page":"580.e1-580.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Aspirin delays the development of preeclampsia"],"prefix":"10.1016","volume":"220","author":[{"given":"David","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.02.034_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.02.034_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2019.02.034_bib3","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib4","doi-asserted-by":"crossref","first-page":"03.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib5","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000335366","article-title":"Protocol for measurement of mean arterial pressure at 11\u201313 weeks\u2019 gestation","volume":"31","author":"Poon","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2019.02.034_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib8","doi-asserted-by":"crossref","DOI":"10.1081\/PRG-100104165","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2019.02.034_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS\u2014a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Stat Comput"},{"key":"10.1016\/j.ajog.2019.02.034_bib10","series-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing","year":"2011"},{"key":"10.1016\/j.ajog.2019.02.034_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/uog.7628","article-title":"Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11\u201313 weeks","volume":"35","author":"Poon","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11\u201313 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2019.02.034_bib13","doi-asserted-by":"crossref","first-page":"203.e1","DOI":"10.1016\/j.ajog.2012.12.016","article-title":"Performance of a first-trimester screening of\u00a0preeclampsia in a routine care low-risk setting","volume":"208","author":"Scazzocchio","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.034_bib14","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2014.04.018","article-title":"Prediction of preeclampsia utilizing the first trimester screening examination","volume":"211","author":"Baschat","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819303862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819303862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:16Z","timestamp":1762079656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819303862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0002937819303862"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.02.034","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin delays the development of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}